Amgen names Ray Jordan Senior Vice President, Corporate Affairs
10 September 2012 | By Amgen
Amgen announced the appointment of Ray Jordan to the new position of senior vice president, Corporate Affairs...
List view / Grid view
News
Biogen Idec sells BENLYSTA royalty rights to DRI Capital managed fund
10 September 2012 | By Biogen Idec
Biogen Idec has sold to a DRI Capital managed fund its royalty and other rights relating to BENLYSTA®...
Lilly announces results from lung cancer study
6 September 2012 | By Eli Lilly and Company
The Phase III POINTBREAK trial did not meet its primary endpoint...
Boehringer Ingelheim and the ETH Zurich announce diabetes and obesity research collaboration
6 September 2012 | By Boehringer Ingelheim
The joint effort will focus on investigating three cell types...
Abbott to collaborate with Astellas in CMV Vaccine Trial
6 September 2012 | By Abbott
Abbott has signed an agreement to collaborate with Astellas Pharma Global Development...
New data for Novartis drug Lucentis® confirms long-term efficacy and safety profile and benefits of individualized treatment
5 September 2012 | By Novartis
New data for Lucentis®...
Roche committed to innovation and growth
5 September 2012 | By Roche
Personalised healthcare leadership and world-class pipeline presented at investor conference...
Pfizer receives EU Marketing Authorization for INLYTA®(Axitinib)
4 September 2012 | By Pfizer
The European Commission has granted marketing authorization for INLYTA® (axitinib)...
Lilly Diabetes launches mobile application for those who support people with Type 1 diabetes
4 September 2012 | By Eli Lilly and Company
Lilly Diabetes launches Lilly Glucagon Mobile App to support #diabetes caregivers...
Tecan and Siloam Biosciences co-market new ELISA system
Tecan and Siloam Biosciences Inc. announce their intent to co-market a new automated low volume, high sensitivity microfluidic ELISA...
U.S. Food and Drug Administration approves BOSULIF® (bosutinib)
4 September 2012 | By Pfizer
“BOSULIF is the third new medicine to be approved by the FDA in just 13 months..."
Republic of Uganda and Merck launch cervical cancer vaccination program
4 September 2012 | By Merck
Cervical cancer is the most common cancer among women in Uganda...
Revestive® (teduglutide) receives European marketing authorization for the treatment of adults with Short Bowel Syndrome (SBS)
4 September 2012 | By F T I Consulting
The European Commission has granted European market authorization for the medicinal product teduglutide...
SPIRIVA®* celebrates 10 years of ongoing commitment to patients and advancing clinical innovation in COPD
3 September 2012 | By Boehringer Ingelheim
SPIRIVA® is the most prescribed COPD maintenance treatment worldwide...
Novartis data at ERS shows efficacy of once-daily COPD portfolio versus comparators, further establishes dual-bronchodilator QVA149
3 September 2012 | By Novartis
Further data from the COPD clinical trial programs...
